BioAge Labs, Inc.

BIOA chart

BioAge Labs, Inc. news

• Weekly Recap: QUELL-CV and QUELL-DME advance and Q3 reports $33.5M net loss

  TradingView · Nov 9, 6:00 AM EST

• BTIG maintains Bioage Labs at Buy, keeps price target at $40

  TradingView · Nov 9, 5:13 AM EST

• BioAge Labs Posts $0.73 Q3 GAAP Loss Per Share as Revenue Drops 85.7%

  TOKENPOST · Nov 7, 5:57 PM EST

• BioAge Labs, Inc. (BIOA) stock price, news, quote and history

  Yahoo Finance Australia · Nov 7, 4:03 AM EST

• BioAge Labs, Inc. (BIOA) Seasonal returns chart

  Yahoo Finance UK · Nov 6, 4:00 PM EST

• BioAge Labs, Inc. (Y7G.DU) Stock Price, News, Quote & History

  Yahoo! Finance Canada · Nov 6, 10:22 AM EST

• What Does BGE-102 Phase 1 Data Mean for BioAge Labs, Inc. (NASDAQ:BIOA) in 2027?

  Kalkine · Nov 6, 7:01 AM EST

• BioAge Labs Reports Q3 2026 Net Loss of $33.5 Million and Revenue of $0.3 Million, Missing Analyst Estimates

  GuruFocus · Nov 5, 8:39 PM EST

• BioAge Labs Inc. (BIOA) Stock Price | Live Quotes & Charts | NASDAQ

  StocksToTrade · Nov 5, 7:30 PM EST

• BioAge Labs, Inc. reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 5, 7:06 PM EST

• Form 8K Bioage Labs Inc For: 5 November By Investing.com

  Investing.com Nigeria · Nov 5, 6:46 PM EST

• Bioage Labs Q3 Results: EPS loss widens to $0.73, sales fall 85%

  scanx.trade · Nov 5, 5:12 PM EST

BioAge Labs, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-05
• 8-K8-K2026-11-05
• 8-K8-K2026-10-02
• 10-Q10-Q2026-08-05
• 8-K8-K2026-08-05
• 8-K8-K2026-06-12
• 8-K8-K2026-05-08
• 10-Q10-Q2026-05-08
• DEF 14ADEF 14A2026-04-21
• 10-K10-K2026-03-24
• 8-K8-K2026-03-24
• 8-K8-K2026-01-22

About BioAge Labs, Inc.

Ticker

BIOA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Emeryville, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1709941

Frequently asked questions